Pattern of pediatric zolpidem ingestions reported to Texas poison control centers, 2000 to 2006

Mathias B Forrester1

  • 1Epidemiology and Disease Surveillance Unit, Texas Department of State Health Services, 1100 W 49th St, Austin, TX 78756, USA. mathias.forrester@dshs.state.tx.us

Pediatric Emergency Care
|January 1, 2009
PubMed

Insights

Young children ingesting zolpidem (a sleep aid) typically experience minor effects and can often be managed at home. This study analyzed unintentional zolpidem exposures reported to poison control centers.

Area of Science:

  • Toxicology
  • Pediatric Medicine
  • Public Health

Background:

  • Zolpidem is a commonly prescribed sedative-hypnotic medication.
  • Accidental pediatric ingestions of medications pose a significant public health concern.
  • Understanding ingestion patterns is crucial for prevention and management strategies.

Purpose of the Study:

  • To characterize the patterns of zolpidem ingestions in young children.
  • To analyze demographic and clinical factors associated with zolpidem ingestions.
  • To determine the medical outcomes of pediatric zolpidem exposures.

Main Methods:

  • Retrospective analysis of zolpidem ingestions in children aged 0-5 years.
  • Data collected from Texas poison control centers between 2000-2006.
  • Exclusion of multiple substance ingestions; analysis of patient demographics, ingestion circumstances, management, and outcomes.

Main Results:

  • A total of 463 unintentional zolpidem ingestions were reported.
  • Most ingestions (92.8%) occurred in the child's home.
  • The majority of cases resulted in no (59.0%) or minor (35.1%) effects, with on-site management in 54.4% of cases.

Conclusions:

  • Pediatric zolpidem ingestions, when isolated, rarely lead to severe outcomes.
  • Home management is frequently appropriate for unintentional pediatric zolpidem exposures.
  • Findings underscore the importance of safe medication storage to prevent childhood poisonings.
Abstract

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Toxidromes: Clinical Features01:30

Toxidromes: Clinical Features

Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...